Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
90,318,827
-
Total 13F shares
-
82,714,633
-
Share change
-
-1,342,326
-
Total reported value
-
$1,270,488,775
-
Put/Call ratio
-
651%
-
Price per share
-
$15.36
-
Number of holders
-
165
-
Value change
-
-$85,984,898
-
Number of buys
-
109
-
Number of sells
-
70
Institutional Holders of Travere Therapeutics, Inc. - COMMON STOCK (TVTX) as of Q2 2023
As of 30 Jun 2023,
Travere Therapeutics, Inc. - COMMON STOCK (TVTX) was held by
165 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
82,714,633 shares.
The largest 10 holders included
ARMISTICE CAPITAL, LLC, Deep Track Capital, LP, BlackRock Inc., JANUS HENDERSON GROUP PLC, STATE STREET CORP, VANGUARD GROUP INC, MACQUARIE GROUP LTD, ORBIMED ADVISORS LLC, PICTET ASSET MANAGEMENT SA, and Point72 Asset Management, L.P..
This page lists
165
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.